Endpoint definition
↥321302 individuals
Apply sex-specific rule None
321302
Check conditions None
321302
Check pre-conditions, main-only, mode, ICD version
884
Check minimum number of events None
884
Include endpoints None
884
Extra metadata
Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS
No definition available.
321302 individuals
Apply sex-specific rule None
321302
Check conditions None
321302
Check pre-conditions, main-only, mode, ICD version
884
Check minimum number of events None
884
Include endpoints None
884
Extra metadata
List of similar endpoints to
Special screening examination for neoplasms
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 852 | 292 | 560 |
| Unadjusted prevalence (%) | 0.28 | 0.17 | 0.41 |
| Mean age at first event (years) | 60.21 | 54.37 | 63.26 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.01 | 0.62 [0.35, 1.10] | 1.0e-1 | 134 |
| 15 years | 0.00 | 0.61 [0.36, 1.02] | 5.8e-2 | 82 |
| 5 years | 0.00 | 1.00 [0.59, 1.70] | 9.9e-1 | 29 |
| 1 year | - | - | - | - |
Index endpoint: Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS – Special screening examination for neoplasms
GWS hits: 3
before Special screening examination for neoplasms
after Special screening examination for neoplasms
Loading survival analyses plot
Loading survival analyses table